Replies to post #4402 on eWellness Healthcare Corp. (EWLL)

[cash4]

I want to believe that so bad, but unfortunately it's not even close to bottom, this goes 3 ticks up and 5 ticks bottom, this was a classic Gap'nTrap.

The dizzying dance where it gives small hope of upwards movement and we're constantly sinking.

I got out of DEC* to come here and I missed a lot of profit because of that, I hate myself for it.

This stock ate all the profits I've made in the last weeks on perfect executions, from PCT*, KNO*, IPI*, CTY* and DEC*, I wasted ours of endless night research just to handed over to these small time crooks.

For me to be where DEC* would've taken me plus what I lost here already EWLL would have to see 0.03, and that's not going to happen...that would be 1000% from these levels..does it look like this company is going to let that happen ?

Don't try to hold the PPS against an avalanche of shares, if the company wants to sell let them sell on the floor, why give them the satisfaction of getting the most money out of our pockets, lower the bid an let them sell at ridiculous prices, they have almost 4 Bil shares to dump.

I'm already flat, they can't do any worse to me.

Once they sell like morons at garbage value and liquidate their shares ..then and only then..it's worth to accumulate..going up against their shares with fresh 100 dollar bills makes no sense, ..get out of their way and let them crash in the wall..then we clean up the notes with a vacuum cleaner at a discount.

http://compliance-sec.com/secfilings/company/ewellness-healthcare/link_files/2020/02-14-2020/FormDEF14C(02-14-2020)EwellnessHealthcare/FormDEF14C.pdf

In addition, a certain number of shares are reserved for issuance with respect to outstanding convertible notes. As of February 3, 2020, the number of shares underlying outstanding convertible notes
is 3,765,995,074.

We have been funding our operations utilizing proceeds from convertible notes and expect to do so until we begin to generate significant revenues from our proprietary physical therapy telehealth operations (“PHZIO”).

As a result of funding the development of PHZIO and the costs of our operations by the issuance of shares of our Common Stock and the requirement of reserving shares underlying convertible notes, we expect in the near future to not have available a sufficient number of authorized but unissued shares of Common Stock for near term corporate purposes.